AG
RVNC

Aperio Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Aperio Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.23M Buy
2020
Q3 		$1.08M Sell
2020
Q2 		$1.09M Sell
2020
Q1 		$725K Sell
2019
Q4 		$844K Buy
2019
Q3 		$575K Buy
2019
Q2 		$448K Buy
2019
Q1 		$205K Buy